2014
Impact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes Mellitus Analysis From 18 Pooled Randomized Trials
Kedhi E, Généreux P, Palmerini T, McAndrew T, Parise H, Mehran R, Dangas G, Stone G. Impact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes Mellitus Analysis From 18 Pooled Randomized Trials. Journal Of The American College Of Cardiology 2014, 63: 2111-2118. PMID: 24632279, DOI: 10.1016/j.jacc.2014.01.064.Peer-Reviewed Original ResearchConceptsDiabetes mellitusRepeat revascularizationMyocardial infarctionLesion complexityStent outcomesCardiac deathType A/B1 lesionsType B2/C lesionsB2/C lesionsPropensity score-matched groupsCoronary lesion complexityTarget vessel revascularizationPatient-level dataB1 lesionsNoncomplex lesionsVessel revascularizationDiabetic statusC lesionsDES eraRandomized trialsRisk factorsTarget lesionsDES safetyTreatment outcomesBaseline differences
2011
EVEROLIMUS-ELUTING VS. PACLITAXEL-ELUTING STENTS. TWO-YEAR RESULTS FROM A PATIENT-LEVEL POOLED ANALYSIS FROM THE SPIRIT II, III, IV AND COMPARE RANDOMIZED TRIALS
Kedhi E, Smits P, Serruys P, Kereiakes D, Parise H, Fahy M, Stone G. EVEROLIMUS-ELUTING VS. PACLITAXEL-ELUTING STENTS. TWO-YEAR RESULTS FROM A PATIENT-LEVEL POOLED ANALYSIS FROM THE SPIRIT II, III, IV AND COMPARE RANDOMIZED TRIALS. Journal Of The American College Of Cardiology 2011, 57: e1824. DOI: 10.1016/s0735-1097(11)61824-x.Peer-Reviewed Original Research